Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |